Skip to main content
. Author manuscript; available in PMC: 2013 Mar 24.
Published in final edited form as: Gut. 2012 Jan 20;62(1):73–82. doi: 10.1136/gutjnl-2011-301551

Table 3.

T cell subclasses, total numbers and ratios comparing samples from patients with necrotising enterocolitis (NEC) with those from non-NEC surgical controls

Acute NEC (n=18) Controls (n=30) p Values*
Total cells 102 882 (56 028; 236 800) 179 489 (107 768; 262 712) 0.30
Live CD3 3344 (1551; 6086) 2800 (1448; 6525) 1.00
CD3CD4 1438 (571; 4000) 1242 (650; 3049) 0.94
CD4CD45RO 538 (182; 1190) 906 (428; 2274) 0.27
CD3CD8 559 (288; 1448) 333 (172; 932) 0.36
Naive Treg 11 (6; 20) 9 (3; 23) 0.64
Treg 44 (18; 80) 100 (33; 164) 0.12
Live CD3 (%) 2.3 (1.1; 5.5) 1.9 (0.6; 4.2) 0.42
CD4/CD3 (%) 46.9 (40.9; 56.6) 48.57 (39.7; 57.3) 0.77
CD45RO/CD4 (%) 46.2 (30.2; 64.6) 65.5 (51.0; 82.3) 0.01
CD8/CD3 (%) 20.5 (11.3; 31.3) 14.5 (10.0; 18.0) 0.04
Naive Treg/CD4 (%) 0.9 (0.6; 1.0) 0.6 (0.2; 1.4) 0.36
Treg/CD4 (%) 2.9 (2.0; 4.6) 6.6 (4.0; 11.8) 0.001
Naive Treg/CD8 (%) 1.5 (0.1; 3.2) 1.2 (0.5; 4.9) 0.62
Treg/CD8 (%) 6.6 (4.5; 9.3) 25.9 (11.0; 47.6) <0.001
*

Wilcoxon rank sum test.

Median (first quartile; third quartile).

Treg defined as viable CD4 CD25high FOXP3high CD127low CD45RO cells.